“Sonidegib Duration of Response in Advanced Basal Cell Carcinoma: Long-term Results from the Phase 2 BOLT Trial”, J of Skin, vol. 2, no. S1, p. S50, Feb. 2018, doi: 10.25251/skin.2.supp.50.